Search
for

    Glossary Cabergoline

    medication that reduces prolactin levels by stimulating dopamine receptors

    Cabergoline is a medication primarily used to treat disorders related to high levels of the hormone prolactin, such as prolactinomas (pituitary gland tumors). It works by stimulating dopamine receptors in the brain, which in turn reduces the production of prolactin. This can help alleviate symptoms like unwanted breast milk production, infertility, and menstrual issues.

    Sort by

    Research 30 of 64

    1. Remission in Cushing disease with cabergoline 2008 · 5 citations
    2. Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment Journal of feline medicine and surgery open reports · 2021 · 2 citations
    3. Cabergoline therapy against hyperadrenocorticism in a dog Deleted Journal · 2024
    4. Efficacy of Letrozole (LE) Combined with Cabergoline (CE) in Comparison to LE alone in ovulation induction among patients with Polycystic Ovarian Syndrome (PCOS) and Hyperprolactinemia (HP) 2020
    5. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea International Journal of Gynecology & Obstetrics · 1995
    6. Cardiometabolic profile of young women with hypoprolactinemia Endocrine · 2022 · 28 citations
    7. The treatment of polycystic ovary syndrome. PubMed · 2004 · 17 citations
    8. Pituitary Macroprolactinoma with Mildly Elevated Serum Prolactin: Hook Effect. PubMed · 2018 · 2 citations
    9. Finasteride and male fertility Journal of Human Reproductive Sciences · 2011 · 1 citations
    10. SAT378 Unusual Case of Hirsutism From Prolactinoma Induced Dihydrotestosterone Elevation Journal of the Endocrine Society · 2023
    11. Evaluation of Hyperandrogenemia in Women with Prolactinoma Endocrinology research and practice. · 2020
    12. Pharmacological Control of Reproduction in the Dog and Cat 2019
    13. Actualités du SOPK Annales D Endocrinologie · 2006
    14. Cutaneous Drug Reaction Case Reports American Journal of Clinical Dermatology · 2003
    15. Hair Loss in Women Seminars in Cutaneous Medicine and Surgery · 2009 · 81 citations
    16. Oral contraceptives and risk of breast cancer in women aged 20–54 years International Journal of Gynecology & Obstetrics · 1995
    17. The dose‐response of percutaneous oestradiol implants on the skeletons of postmenopausal women International Journal of Gynecology & Obstetrics · 1995
    18. Minoxidil versus Nitroglycerin: A Prospective Double-Blind Controlled Trial in Transcutaneous Erection Facilitation for Organic Impotence The Journal of Urology · 1991 · 74 citations
    19. Endocrine control of benign prostatic hyperplasia Andrology · 2016 · 97 citations
    20. Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male Urologic Clinics of North America · 2016 · 70 citations
    21. Polycystic Ovary Syndrome and Its Differential Diagnosis Obstetrical & Gynecological Survey · 2006 · 42 citations
    22. Parkinson's disease and skin 2021 · 28 citations
    23. Hormone therapy in acne Indian Journal of Dermatology, Venereology and Leprology · 2013 · 24 citations
    24. Treatment of androgen excess in females: Yesterday, today and tomorrow Gynecological Endocrinology · 1997 · 9 citations
    25. Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study Swiss Medical Weekly · 2025 · 8 citations
    26. Diagnosis and Management of Infertility due to Anovulation Infertility · 2011 · 2 citations
    27. Chemically Induced Hair Loss/Alopecia Springer eBooks · 2019
    28. Poster Abstracts Fundamental & Clinical Pharmacology · 2017
    29. Les hormones sexuelles et la peau : questionnaire à l'attention des vétérinaires praticiens. Mise à jour bibliographique et synthèse HAL (Le Centre pour la Communication Scientifique Directe) · 2014
    30. Gonads John Wiley & Sons, Ltd eBooks · 2013